Manufacturing operations and controls are important to ensure the identity, strength, safety, and purity of pharmaceutical products. Key aspects include sanitizing manufacturing premises, preventing mix-ups and cross contamination, processing intermediates and bulk products while maintaining quality, conducting packaging operations with controls, in-process quality control testing during manufacturing and packaging, and only releasing finished products that meet all requirements after quality approval. Maintaining proper documentation and investigating any deviations or unusual events are also important parts of manufacturing and quality control.
Aseptic process tech & advanced sterile product mfg rashmi nasareRASHMINasare
Aseptic process technology & advanced sterile product manufacturing technology it is done for doing in process quality control test for sterile product
A vendor audit is a vehicle used by pharmaceutical companies, and other large companies as well, to inspect and evaluate a vendor’s quality management system, as well as its practices, products, and documentation.
The need to conduct vendor audits stems from a higher need for quality control in an industry that needs to be more regulated than any other industry in the world.
Reason why organizations use audits is to reduce cost and improve quality control
The objective of vendor audit is to develop an audit function comprising of qualified resources to effectively perform compliance audits to ensure that the contracts are being executed in accordance with the intent and address the net benefit to include cost recoveries, process improvement savings, fraud improvement and identification of hidden risks.
In order to reduce the cost pharmaceutical companies have increasingly become dependent on their supplier/ out sourcing partners for customer success. Though it has drastically reduced the production cost for companies, there is a heightened supplier risk and lack of visibility into supplier processes.
To gain an insight into supplier process and eliminate the risks, FDA encourages companies to conduct GMP supplier audit at the manufacturing premises of the supplier.
According to GMP code, it is sole responsibility of pharmaceutical industry to ensure that the suppliers manufacturing process, analytical tests and examinations are carried out reliably by the supplier and are in compliances with the applicable standards and regulations.
After the audit supplier must provide an appropriate corrective action plan with measures that that will be implemented by the supplier within a defined time frame to the manufacturer.
Aseptic process tech & advanced sterile product mfg rashmi nasareRASHMINasare
Aseptic process technology & advanced sterile product manufacturing technology it is done for doing in process quality control test for sterile product
A vendor audit is a vehicle used by pharmaceutical companies, and other large companies as well, to inspect and evaluate a vendor’s quality management system, as well as its practices, products, and documentation.
The need to conduct vendor audits stems from a higher need for quality control in an industry that needs to be more regulated than any other industry in the world.
Reason why organizations use audits is to reduce cost and improve quality control
The objective of vendor audit is to develop an audit function comprising of qualified resources to effectively perform compliance audits to ensure that the contracts are being executed in accordance with the intent and address the net benefit to include cost recoveries, process improvement savings, fraud improvement and identification of hidden risks.
In order to reduce the cost pharmaceutical companies have increasingly become dependent on their supplier/ out sourcing partners for customer success. Though it has drastically reduced the production cost for companies, there is a heightened supplier risk and lack of visibility into supplier processes.
To gain an insight into supplier process and eliminate the risks, FDA encourages companies to conduct GMP supplier audit at the manufacturing premises of the supplier.
According to GMP code, it is sole responsibility of pharmaceutical industry to ensure that the suppliers manufacturing process, analytical tests and examinations are carried out reliably by the supplier and are in compliances with the applicable standards and regulations.
After the audit supplier must provide an appropriate corrective action plan with measures that that will be implemented by the supplier within a defined time frame to the manufacturer.
Analysis of Raw materials…..
This topic comes under Quality Control and Quality Assurance…….
This is useful for M.Pharm (Pharmaceutical Quality Assurance) Students who studying in Fist year sem I......
This Presentation Contain following...
#Definition
#Purchase Specification
#GMP & WHO guidelines for handling of raw materials
#Control on Raw Materials
#Sampling of Raw Materials
#Raw Materials Testing
Thanks for Help and Guidance of Dr. F. A. Tamboli Sir and Dr.Mrs. N.M.Bhatia Madam
In this slide contains definition, validation plan, types of Qualification of Dry Powder Mixture.
Presented by: Ravi Sanker babu .D.V (Department of pharmaceutical analysis and quality assurance).RIPER, anantapur
What is IPQC & IPQC Test
Appearance
Drug content determination
pH
Sensitivity test
Spreadability
Rate of absorption
Extrudability
Consistency Test
Rheology & Viscosity
Role of quality system and audits in pharmamaceuticalganpat420
Introduction
cGMP Regulations
Quality Assurance Function
Quality Systems Approach
Management Responsibilities
Resources
Manufacturing Operations
Evaluation Activities
Transitioning to Quality Systems Approach
Audit Checklist for Drug Industry
As the audit proceeds, there might arise some situations where the facts indicate there is a failure, either partially or wholly, of the quality management system, such a situation is called nonconformity/ deficiencies”.
Role of quality systems and audits in pharmaceutical manufacturing environmentMalay Pandya
By regulation, appropriate practice, and common sense, quality assurance (QA) is a critical function in the pharmaceutical manufacturing environment. The need for an independent unit to audit and comment on the appropriate application of standard operating procedures, master batch records, procedures approved in product applications, and the proper functioning of the quality control (QC) unit is paramount.
This helps assure that products are manufactured reliably, with adherence to approved specifications, and that current good manufacturing practices (cGMP) are maintained in conformance to regulation, both in the facility in general and the microenvironment of each product ’s manufacturing sequence.
Manufacturing Control Systems. J R Controls provides control systems for the manufacturing industry. A typical control system will monitor the progress of parts through the manufacturing and finishing process.
Analysis of Raw materials…..
This topic comes under Quality Control and Quality Assurance…….
This is useful for M.Pharm (Pharmaceutical Quality Assurance) Students who studying in Fist year sem I......
This Presentation Contain following...
#Definition
#Purchase Specification
#GMP & WHO guidelines for handling of raw materials
#Control on Raw Materials
#Sampling of Raw Materials
#Raw Materials Testing
Thanks for Help and Guidance of Dr. F. A. Tamboli Sir and Dr.Mrs. N.M.Bhatia Madam
In this slide contains definition, validation plan, types of Qualification of Dry Powder Mixture.
Presented by: Ravi Sanker babu .D.V (Department of pharmaceutical analysis and quality assurance).RIPER, anantapur
What is IPQC & IPQC Test
Appearance
Drug content determination
pH
Sensitivity test
Spreadability
Rate of absorption
Extrudability
Consistency Test
Rheology & Viscosity
Role of quality system and audits in pharmamaceuticalganpat420
Introduction
cGMP Regulations
Quality Assurance Function
Quality Systems Approach
Management Responsibilities
Resources
Manufacturing Operations
Evaluation Activities
Transitioning to Quality Systems Approach
Audit Checklist for Drug Industry
As the audit proceeds, there might arise some situations where the facts indicate there is a failure, either partially or wholly, of the quality management system, such a situation is called nonconformity/ deficiencies”.
Role of quality systems and audits in pharmaceutical manufacturing environmentMalay Pandya
By regulation, appropriate practice, and common sense, quality assurance (QA) is a critical function in the pharmaceutical manufacturing environment. The need for an independent unit to audit and comment on the appropriate application of standard operating procedures, master batch records, procedures approved in product applications, and the proper functioning of the quality control (QC) unit is paramount.
This helps assure that products are manufactured reliably, with adherence to approved specifications, and that current good manufacturing practices (cGMP) are maintained in conformance to regulation, both in the facility in general and the microenvironment of each product ’s manufacturing sequence.
Manufacturing Control Systems. J R Controls provides control systems for the manufacturing industry. A typical control system will monitor the progress of parts through the manufacturing and finishing process.
Introduction to manufacturing operations, Sanitation, Cross-contamination, Packaging, IPQC, time limitation, Expiration,Calculation of Yield, Production record review, process deviation
Objectives of CGMP
Layout of buildings, services, equipments & maintenance
Production organization
material management
handling and transportation
inventory management &control
Production and planning control
Sales forcasting
Budget and cost control
Industrial and personnel relationship
Total quality management
QUALIFICATION OF MANUFACTURING EQUIPMENTSANKUSH JADHAV
it gives the information about qualification of various manufacturing equipment which is used into the pharmaceutical labs. (only for information purpose)
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
Operation “Blue Star” is the only event in the history of Independent India where the state went into war with its own people. Even after about 40 years it is not clear if it was culmination of states anger over people of the region, a political game of power or start of dictatorial chapter in the democratic setup.
The people of Punjab felt alienated from main stream due to denial of their just demands during a long democratic struggle since independence. As it happen all over the word, it led to militant struggle with great loss of lives of military, police and civilian personnel. Killing of Indira Gandhi and massacre of innocent Sikhs in Delhi and other India cities was also associated with this movement.
Honest Reviews of Tim Han LMA Course Program.pptxtimhan337
Personal development courses are widely available today, with each one promising life-changing outcomes. Tim Han’s Life Mastery Achievers (LMA) Course has drawn a lot of interest. In addition to offering my frank assessment of Success Insider’s LMA Course, this piece examines the course’s effects via a variety of Tim Han LMA course reviews and Success Insider comments.
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
Acetabularia Information For Class 9 .docxvaibhavrinwa19
Acetabularia acetabulum is a single-celled green alga that in its vegetative state is morphologically differentiated into a basal rhizoid and an axially elongated stalk, which bears whorls of branching hairs. The single diploid nucleus resides in the rhizoid.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
Safalta Digital marketing institute in Noida, provide complete applications that encompass a huge range of virtual advertising and marketing additives, which includes search engine optimization, virtual communication advertising, pay-per-click on marketing, content material advertising, internet analytics, and greater. These university courses are designed for students who possess a comprehensive understanding of virtual marketing strategies and attributes.Safalta Digital Marketing Institute in Noida is a first choice for young individuals or students who are looking to start their careers in the field of digital advertising. The institute gives specialized courses designed and certification.
for beginners, providing thorough training in areas such as SEO, digital communication marketing, and PPC training in Noida. After finishing the program, students receive the certifications recognised by top different universitie, setting a strong foundation for a successful career in digital marketing.
2. INTRODUCTION
SANITATION AND MANUFACTURING PREMISES
MIX – UP AND CROSS CONTAMINATION
SOUCES OF CONTAMINATIO AND MIX- UP
PROCCESSING OF INTERMIDIATE AND BULK
PRODUCT
PACKAGING OPERATIONS
IPQC IN MANUFACTURING AND PACKAGING
RELEASE OF FINISHED PRODUCT
CONTENTS
2
3. SIGNIFICANCE
MANUFACTURING :TO produce goods and service of
quality accepted by customers in desired quantities
according to time schedules and at minimum cost.
CONTROL: Producing right kind of goods and services that
satisfy customers need.
Minimizing cost of producing goods or services
Manufacturing operation and controls are as follows :
1.Identity-Refers to correct identification of
product,people,materials,machines,equipment & locations
where mfg.activities are carried out.
2.Strength-refers to concentration of active substance in
desired quantity in each unit of the finished pharmaceutical
product.
3
INTRODUCTION
4. 3.Safety-Person who is going to consume the
product. Safety of people should be also
considered. Mfg.operations should be safe
while products are being mfg.
4.Purity-Feedom from cross contamination
and staff (Expert technical staff) approved
by FDA. They from mix-ups.
Operation done-Qualified technical should be
trained, have appropriate
knowledge,skill,attitude to carry out their
responsibilities.
4
5. SANITATION OF MFG.PREMISES
Mfg.areas –state of cleanliness & sanitary conditions.
Must use validated cleaning &sanitising procedures.
Identify Certain locations-collection of
dust,debris,waste/trash material.
Containers of suitable size & shape made from plastic or
recycled plastic bags can be put into containers & trash
collected.
At regular intervals-twice in shift-deposited at backside of
plant in room away from processing area-central waste
material sit/ scrapyard.
.
5
6. Define the detergent, its concentration, frequency of
cleaning, persons responsible for doing & supervising job.
Record of activities should be made, with date and time of
cleaning, person who performed and supervised job.
After cleaning activity area should be disinfected by using
suitable method, using proper concentration-records-
appropriate people-regular time-supervised by
housekeeping supervisor-SOP.
Documents required-1.SOP- on
housekeeping,covering,cleaning & disinfection of various
areas.
2.Reports of cleaning & disinfection activities.
6
7. MIX-UPS & CROSS CONTAMINATION
Big danger & precaution should be taken to avoid the
same.
Mix-up-undesired material into desired material, visibly
seen e.g.- cartons of one product into another, tablets of
one product with another product which has different size,
shape or color etc.
Contamination-some material where it is not desired, not
visible e.g.- fine dust of one product into another product,
fine black particles into processing materials
7
8. SOURCES OF CONTAMINATION AND MIX-
UPS
Materials
People
Machine and operations
Areas etc.
8
9. Materials
Improper handling of material lead to
spillage on ground & cause contamination
Broken containers
Dusty uncontrolled activities
9
10. People
Indisciplined activities
Infectious nature of skin/body parts
Trained people
By keeping movements restricted
Using hand gloves
Mask
Proper uniform
Medically strictly examined
Infectious disease/open wound treated by
qualified doctor.
10
11. Machine and operations
Must be clean
Covered when not in use
Should be checked before use to avoid
contamination
E.g.-Discharge of exhausted
dust,smoke,fumes,gases should be
monitored.
Sensitive material-Beta lactam antibiotics
,toxic drugs
SOPs ,records should be kept
11
12. Mfg Areas-Aseptic filling area
Other sterile area
Non-sterile processing area
Corridors, cleaning rooms, outside areas of
the plant
SOPs
12
13. CONTROLLING OF CONTAMINATION &
MIX-UPS
Exhaust system -proper air filtration & dust collection
Separate air handling unit for each work station-avoid
particulate contamination
Different rooms at different air pressure
Packaging lines should be separate at 1.2 to 1.5 meters-
avoid mix-ups
SOPS-PACKAGING LINE
Similar looking products-packed/processed.
13
14. D. Trained people
G. Technical/Organizational Measures
Production in segregated area
Providing appropriate airlocks, pressure
differentials, air extraction
Minimizing risk of contamination by
recirculation/reentry of untreated
Wearing protective clothing
14
15. PROCESSING OF INTERMEDIATE & BULK
PRODUCT
Starting from the receipt of raw materials-to ready for
packaging into their primary-finished packs-points to kept
in mind that identity,strength,safety & purity of the
product should be maintained—
1.Before stating process, the material received from the
stores should be checked for the identity & quantity-
done by labels on containers & by weighing or measuring
quantity of materials.
2.Process area & equipment must be clean & no traces of
previous product.
3.Environmental conditions must be with processing
requirement for e.g.temp.relative humidity, pressure etc.
15
16. 4.Containers for filling of finished products should be clean to
acceptable level of cleanliness. Bulk containers –storage of
in-process materials also be cleaned.
5.Yield of materials at all critical stages of operations like
granulation,compression,filling operations of capsules,
liquid bottles etc.and compared with T.Y .expected, any
abnormal deviations must be investigated & corrective
action taken.
6.Check pipelines and other pieces of equipment used for
transportation of products from one area to another area
corrected in a correct manner. Such thing should thoroughly
cleaned/sanitised to get desired level of limits of microbial
presence.
16
17. PACKAGING OPERATIONS
As for mfg.operations ,packaging operations also follow
precautions to get a good quality product at end.
Following points should be considered.
1.Avoid risk of contamination and mix-ups
2.All packaging equipment & lines must be cleaned before
staring a fresh packaging activity. Line clearance—record
maintained.
3.Each packaging equipment and line identified by fixed
board indicating following information-Name of product,
batch no., Pack size, date of packing.
17
18. 4.Normally filling & sealing should be followed by labelling
and final packing. If labelling is delayed appropriate steps
should be taken to prevent mix-ups.To avoid this no batch
should be taken for packing unless all the packing
materials are available in full quantities.
-Bulk tablets(for want of foils)
-Strips or blisters(for want of cartons)
-Filled cartons(for want of shippers) such situation must be
avoided.
5.Over printing on labels,cartons,coated tablets etc.should be
carefully planned
6.On line verification of all labels by automated electronic
beam helpful in preventing mix-ups
7.Empty packet detection in tab/cap. should be used.
18
19. 9.Online packaging checks should be carried out for
following-
a.Genreal appearance of the package
b.Completeness of package
c.Correctness of pack & packaging materials
d.Correctness of over printed details
e. Correct version of printed packaging material is used.
f.Weight check of carton & shipper may be useful.
10.Products which are involved in an unusual event during
packaging operations should be fully investigated-record
made-packed after approval of authorized person-
additional Q.A.dept.
19
20. 11.Any significant or unusual discrepancy observed then it
should be investigated & satisfactorily accounted before
release.
12.After completion any unused batch coded packaging
materials should be destroyed and the destruction
recorded.
Documents Required
1.BPCR
2.SOP & record of IPQC
3.Deviation records if any
4.Incident reports if any
20
21. IPQC IN Mfg & Packaging
A For Mfg.Operations-
b.Assay,moisture,angle of repose at end of granulation
c.Physical parameters of compression of tablets
-Weight
-Thickness
-Hardness
-Friability
-Disintegration test
-Dissolution test
21
22. d. Fill weight/vol. in amp./liq. Orals etc.
e. pH of solution before filling
f. Bulk volumes of liquids etc.
g. Environmental conditions verification
e.g.temp. etc.
22
23. b.For Packaging Operations-
a. Packaging operations/lines continually
monitored to sure the integrity of finished
products not compromised.SOP & check
list should regularly signed by trained
people.
b. Automated controls & monitors should be
checked regularly during production
c. Online control of the product-
1.General appearance of the package &
physical defects if any
23
24. 2.Fill weights,volumes,unit quantities etc.
3.Completeness of package-all components
of the pack without fail
4. Correctness of all materials used.
5. Correctness of over printed details
6.Correct functioning of all on line monitors.
7.Environmental conditions records- temp.,
humidity etc
8.Collecton of samples for testing & retention
should be recorded. Tested/Inspected
samples should not be returned back
24
25. RELEASE OF FINISHED PRODUCTS
Last activity
Move into commerce freely
Done with great care
1.Finished products must be placed in quarantine
2.Samples of product taken at intervals during packaging
process retained for examination by quality control
laboratory
3.Doccumentation should be reconciled, completed/sent for
a complete documentation audit
4.All parameters are satisfied along with Q.C. release the
product from its quarantine status
25
26. 5.Finished product should be released for
sale from Q.A .dept
Documents required-
Batch release SOP & reports
26
27. REFERENCE
• Manohar A. Potdar “Pharmaceutical Quality Assurance” Nirali Publications, 6th
edition, 2017.
• Sawant R., Hapse S., “Fundamentals of Quality Assurance Techniques” 2nd
edition, Career Publications, May 2016.
27